High-Grade Serous Ovarian Cancer — Trials

High-Grade Serous Ovarian Cancer — Trials · CancerIndex

Clinical trials

Registered studies

28 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 13
Recruiting: 8
Ph III recruiting: 1
Growth YoY: —
Industry share: 46%
Top sponsor: University Health Network, Toronto
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05281471	Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)	recruiting	Phase 3	186	Genelux CorporationINDUSTRY	1	Aug 26, 2026	clinicaltrials

Data updated 22 days agoSource updated Aug 26, 2026source: clinicaltrials